C.R. Bard Buys FlowCardia, Inc. For $80 Million
5/21/2010 8:17:51 AM
More...
|
FlowCardia, Inc. Launches FlowMate(TM) Injector to Optimize Performance of CROSSER(R) CTO Recanalization Catheter
10/6/2009 11:30:01 AM
More...
|
FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer
7/23/2009 11:06:33 AM
More...
|
FlowCardia, Inc. Appoints Deborah DeFilippo CFO
6/18/2008 8:04:17 AM
More...
|
FlowCardia, Inc. Launches Peripheral CROSSER(R) Catheter Portfolio in the US
12/11/2007 11:19:52 AM
More...
|
FlowCardia, Inc. Appoints Chris Barys Senior VP, Sales
12/5/2007 12:55:09 PM
More...
|
FlowCardia, Inc. Announces Final Enrollment in the PATRIOT Peripheral Study With the CROSSER(TM) Family of CTO Recanalization Catheters
9/12/2007 9:58:02 AM
More...
|
FlowCardia, Inc. Raises $30 Million in Series C Financing
8/30/2007 6:48:55 AM
More...
|
FlowCardia, Inc. Announces Availability Of The Peripheral CROSSER(TM) Catheter Portfolio In Europe
1/25/2007 12:04:42 PM
More...
|
FlowCardia, Inc. Announces 510(k) Clearance For The CROSSER(TM) 14 Chronic Total Occlusion Recanalization System
1/23/2007 9:47:56 AM
More...
|
|